Vale, C. L., Burdett, S., Fisher, D. J., Navani, N., Parmar, M. K., Copas, A. J., & Tierney, J. F. (2015). Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials(). Clin Lung Cancer.

Vale, Claire L., Sarah Burdett, David J. Fisher, Neal Navani, Mahesh K.B Parmar, Andrew J. Copas, و Jayne F. Tierney. "Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials()." Clin Lung Cancer 2015.

Vale, Claire L., et al. "Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials()." Clin Lung Cancer 2015.